Communication of Launch Prices by Drug Companies, 2022-2024
ABSTRACT Objective: To examine how drug manufacturers disclosed prices for new molecular entities approved by the FDA between 2022 and
Read MoreABSTRACT Objective: To examine how drug manufacturers disclosed prices for new molecular entities approved by the FDA between 2022 and
Read MoreThroughout 2025, the story of pharma manufacturing has been dominated by regulatory intervention. The Trump administration has taken steps to
Read MoreBig pharma has continually called for rapid policy change in Europe to maintain the flow of capital into the continent.
Read MoreThe UK has reduced the innovative medicines rebate rate for 2026 through the VPAG scheme down to 14.5%. Image credit:
Read MoreInvestors are currently so focused on one type of drug that even good companies are being left on the sidelines.
Read MoreImage created with Gemini Western drug executives long treated China as little more than a sales target. Think more than
Read MoreThe role of medical affairs in the pharmaceutical industry has evolved significantly, shifting from a reactive function to a proactive,
Read MoreMerck (MRK 1.07%) has taken its shareholders on a wild ride of late — from last March’s record high of
Read MoreThis drugmaker has a strong portfolio of best-selling drugs and a growing pipeline. Pharmaceutical stocks have been on fire this
Read MoreARTICLE CONTINUES BELOW VIDEO The trailer of Nivin Pauly‘s Malayalam web series Pharma was released by the makers on Friday.
Read More